BE725169A - - Google Patents
Info
- Publication number
- BE725169A BE725169A BE725169DA BE725169A BE 725169 A BE725169 A BE 725169A BE 725169D A BE725169D A BE 725169DA BE 725169 A BE725169 A BE 725169A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR132112A FR6978M (xx) | 1967-12-13 | 1967-12-13 | |
FR149541 | 1968-04-25 | ||
FR159646A FR7978M (xx) | 1968-07-18 | 1968-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE725169A true BE725169A (xx) | 1969-05-16 |
Family
ID=27244735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE725169D BE725169A (xx) | 1967-12-13 | 1968-12-09 |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE725169A (xx) |
CH (1) | CH510617A (xx) |
DE (1) | DE1814607A1 (xx) |
GB (1) | GB1244185A (xx) |
NL (1) | NL6817989A (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2755224A1 (de) * | 1976-12-15 | 1978-07-13 | Procter & Gamble | Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung |
GB8304990D0 (en) * | 1983-02-23 | 1983-03-30 | Procter & Gamble | Detergent ingredients |
GB2349880A (en) * | 1999-05-10 | 2000-11-15 | Secr Defence | (Thio)morpholinium salts having SHG activity |
US6436916B1 (en) * | 2000-10-12 | 2002-08-20 | Alvin Guttag | Ibuprofen-aspirin and hydroxymethylacylfulvene analogs |
-
1968
- 1968-12-09 BE BE725169D patent/BE725169A/xx unknown
- 1968-12-12 GB GB5919568A patent/GB1244185A/en not_active Expired
- 1968-12-13 CH CH1862668A patent/CH510617A/fr not_active IP Right Cessation
- 1968-12-13 DE DE19681814607 patent/DE1814607A1/de active Pending
- 1968-12-13 NL NL6817989A patent/NL6817989A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NL6817989A (xx) | 1969-06-17 |
CH510617A (fr) | 1971-07-31 |
GB1244185A (en) | 1971-08-25 |
DE1814607A1 (de) | 1969-07-24 |